CMS ACCESS Model 2026: Medicare Approves Noom, Verily, and Whoop to Treat Chronic Disease — What Your Reaction Reveals About Your Health Autonomy Type

# CMS ACCESS Model 2026: Medicare Approves Noom, Verily, and Whoop to Treat Chronic Disease — What Your Reaction Reveals About Your Health Autonomy Type

> **Quick answer:** Starting July 5, 2026, Medicare's new CMS ACCESS model allows 150+ digital health companies — including Noom (weight management), Verily (Google's life science arm), and Whoop (wearable fitness tracker) — to provide tech-enabled chronic disease care for conditions like diabetes, hypertension, musculoskeletal pain, and depression. Payments to providers are tied to actual health outcomes, not just service delivery. Whether you find this exciting or alarming reflects a fundamental aspect of your health autonomy personality — and understanding that type determines how well you'll actually use this program.

For the first time in Medicare's six-decade history, an algorithm tracking your sleep, blood pressure, and blood sugar could become your primary chronic disease manager. The CMS ACCESS model — Advancing Chronic Care with Effective Scalable Solutions — launches July 5, 2026, and the companies approved to run it read less like a hospital roster and more like a Silicon Valley investor portfolio.

## What the CMS ACCESS Model Actually Is (And Is Not)

The ACCESS model is a 10-year voluntary pilot program from the CMS Innovation Center, the experimental arm of the Centers for Medicare and Medicaid Services. It does not replace traditional Medicare — it runs alongside it. But it fundamentally changes who can get paid to manage your chronic condition.

Under the old model, only licensed clinical providers — doctors, nurse practitioners, care coordinators at hospitals — could bill Medicare for chronic care management. Under ACCESS, digital health companies, wearable device makers, AI coaching platforms, and app-based wellness programs can now receive direct, recurring Medicare payments to manage the same conditions.